As GLP-1 drugs like Ozempic, semaglutide, and Wegovy continue to gain popularity, many patients are achieving impressive weight loss
The underlying tooth structure becomes exposed, leading to sensitivity, increased cavity risk, and potential structural weakness
Looking ahead, the market is expected to continue growing as breakthroughs in novel molecular designs, oral formulations, and dual-target drugs push the boundaries of GLP-1 drug innovation
FLORA LICHTMAN: I mean, on the other hand, were seeing some people eating way too little on these drugs and developing nutritional deficiencies
Obesity treatment guidelines emphasize that GLP-1 medication should be combined with a reduced-calorie diet and increased physical activity (source)
How MEDVi compares to alternatives MEDVi does not exist in a vacuum